Table 1.
No DM (N = 1661) |
DM (N = 373) |
p value | |
---|---|---|---|
BMI | 26.8 ± 4.1 | 28.8 ± 4.7 | < 0.001 |
Sex | |||
♂ | 1313 | 295 | 0.99 |
♀ | 348 | 78 | |
% female | 21.0% | 20.9% | 0.91 |
Age (years) | 62.8 ± 12.4 | 66.5 ± 12.2 | < 0.001 |
Hypertension | 883 (53%) | 291 (78%) | < 0.001 |
Previous MI | 198 (11.9%) | 83 (22.2%) | < 0.001 |
Previous PCI | 244 (14.7%) | 92 (24.7%) | < 0.001 |
Previous CABG | 62 (3.7%) | 36 (9.7%) | < 0.001 |
Previous stroke | 29 (1.7%) | 18 (4.8%) | < 0.001 |
Previous TIA | 18 (1.1%) | 15 (4.0%) | < 0.001 |
ACS type | |||
STEMI | 948 (57.1% | 174 (46.7%) | < 0.001 |
NSTEMI | 663 (39.9%) | 180 (48.2%) | |
UA | 50 (3.0%) | 19 (5.1%) | |
LVEF (%) | 51.7 ± 11.2 | 48.9 ± 12.3 | < 0.001 |
Heart rate (BPM) | 75.5 ± 16.0 | 78.4 ± 15.7 | 0.001 |
Systolic BP (mmHg) | 130.1 ± 23.5 | 131.9 ± 23.1 | 0.18 |
Diastolic BP (mmHg) | 75.7 ± 14.5 | 75.4 ± 16.5 | 0.70 |
HDL-c (mmol/L) | 1.2 ± 0.3 | 1.1 ± 0.3 | < 0.001 |
LDL-c (mmol/L) | 3.3 ± 1.1 | 2.7 ± 1.2 | < 0.001 |
Triglycerides (mmol/L) | 1.005 (0.66–1.53) | 1.14 (0.81–1.83) | < 0.001 |
Cholesterol (mmol/L) | 5.0 ± 1.2 | 4.5 ± 1.4 | < 0.001 |
Leukocytes (g/L) | 9.7 (7.52–12.2) | 9.34 (7.4–12.1) | 0.197 |
CRP (mg/L) | 2.5 (1.1–7) | 3.9 (1.6–11.1) | < 0.001 |
Glucose (mmol/L) | 6.6 ± 1.9 | 9.8 ± 4.6 | < 0.001 |
HBa1c (%) | 5.8 ± 0.3 | 7.6 ± 1.9 | < 0.001 |
hs troponin T (µg/L) | 0.20 (0.06–0.71) | 0.19 (0.057–0.681) | 0.49 |
Creatine kinase (U/L) | 235 (114–539) | 185 (93–419) | < 0.001 |
nt-probnp (ng/L) | 337 (113–1155) | 633 (192–2325) | < 0.001 |
Cyr61 (pg/mL) | 510 (340–951) | 487 (344–780) | 0.25 |
BMI body mass index, CRP C-reactive protein, HBA1C haemoglobin A1c, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, LVEF left ventricular ejection fraction, STEMI ST segment elevation myocardial infarction, NSTEMI non ST-segment elevation myocardial infarction, UA unstable angina